introduced the Dietary Supplement Listing Act, to require dietary supplement manufacturers to register their products with the U.S. Food and Drug Administration (FDA)
Require dietary supplement manufacturers to register their products with the FDA and provide product and ingredient information to improve transparency and oversight.
Occurrences
Evidence
Action: Ms. Dexter introduced the following bill; which was referred to the Committee on Energy and Commerce. Short title: Dietary Supplement Listing Act of 2026. Full title: To improve transparency and the availability of information regarding dietary supplements by amending the Federal Food, Drug, and Cosmetic Act to require manufacturers of dietary supplements to list dietary supplements with the Food and Drug Administration.
Assessments
Dexter introduced H.R. 8370, the Dietary Supplement Listing Act of 2026, during her federal House term, and the bill directly matched the promise by requiring dietary supplement listing with FDA and product/ingredient transparency. However, the evidence shows only introduction and committee referral, with no enactment or implemented FDA registration requirement. This is a serious legislative attempt but not delivery of the promised outcome.